Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Abstract—Numerous morphopathological observations of the
placenta, membranes and umbilical cord detect the ascending
intrauterine infection and the placental vasculopathy as being
dominant in the etiopathogeny of preterm labor.
When it is possible to exclude the vasculopathy early, in the
asymptomatic phase of the intrauterine infection by means of precise
and rapid tests, such as serum C-reactive protein dosing, it results the
necessity of routinely performing the histopathologic exam of the
conception product, as an essential step of orienting the standard
complex investigation of the recurrent abortion.
The thrombophilia defects can generate either extended placental
thromboses or defects of placentation and embryonic implantation. It
is thus necessary to introduce in the standardized investigation of the
recurrent abortion the repeated screening for resistance to activated C
protein, the molecular diagnosis for Leiden mutation of coagulation
factor V, antithrombin III dosing, protein C and S concentrations,
factor XII, the fibrinogen, the plasminogen, the normality of the
fibrin plate lysis, congenital or acquired hyperhomocysteinaemia and
to demonstrate in the laboratory the antiphospholipid antibodies that
are persistent in the peripheral blood.
Keywords—abortion, thrombophilia, chorioamnionitis, C-
reactive protein, histopathology.
I. INTRODUCTION
HE abortion constitutes the most frequent complication of
a pregnancy (affecting 15% of gestations [1]), and it's
financial and emotional impact becomes considerable in the
situation of recurrent abortions (defined as the loss of at least
three consecutive pregnancies [2]) which, in 20% of cases are
appearing in the second gestational trimester [3]. Nonetheless,
in 1995, Wolf and Horger [4] focus the community’s attention
C. A. Bulucea is with the University of Medicine and Pharmacy of
Craiova, Obstetrics and Gynecology Department, Romania (e-mail:
N. E. Mastorakis is with the Military Institutions of University Education -
Hellenic Naval Academy, Greece (e-mail: [email protected])
M. F. Paun is with the University of Medicine and Pharmacy of Craiova,
Obstetrics and Gynecology Department, Romania.
A. Patrascu is with the University of Medicine and Pharmacy of Craiova,
Obstetrics and Gynecology Department, Romania.
A. D. Neatu is with the University of Medicine and Pharmacy of Craiova,
Obstetrics and Gynecology Department, Romania (e-mail:
on the necessity of a standardized investigation of recurrent
abortion.
II. ANALYSIS AND DISCUSSION
Romero and collaborators [5, 6] and Arias and team [7]
introduced, and the studies of Rai et al [3, 8, 9, 10] and Spong
et al [11] supported, the valuable notion of histopathologic
placental screening for intrauterine ascending infectious
lesions and vascular placental lesions.
Numerous morphopathologic observations of the conception
product are systematically detecting, but in various
proportions, both in late abortion as well as in preterm labor
(that are overlapping, between weeks 20 to 28 of the gestation
[12, 13]) the placental ischemia (fig. 1) and/or the acute
amniochoriodecidual inflammation (fig. 2) as the most
frequently involved pathological processes in the multifactorial
and little understood etiology of the preterm labor [14, 15, 16,
17, 18].
Fig. 1 Old placental infarction. Large areas of accelerate aging of
chorionic villi that appear abnormally small, avascular, with intense
sclera hyalinization. (Hematoxylin-Eosin; ob.10)
Romero and collaborators [5, 6] reach the conclusion that in
preterm labor, with or without premature rupture of
membranes, the histopathologic examination of the placenta is
a valuable and non-invasive screening for the possibility of
microbial invasion of the amniotic cavity, because,
systematically, severe subclinical acute chorioamnionitis,
funiculitis and umbilical vasculitis, as well as the marginal or
Histopathologic exam of the placenta,
membranes and umbilical cord – essential step
in orienting the standard complex investigation
of recurrent abortion
Carmen A. Bulucea, Nikos E. Mastorakis, Mariana F. Paun, Anca Patrascu and Alina D. Neatu
T
Recent Researches in Geography, Geology, Energy, Environment and Biomedicine
ISBN: 978-1-61804-022-0 188
mixed inflammation of the choriodecidua are tightly correlated
to the positive culture of the amniotic fluid obtained via
amniocentesis (fig. 3, fig. 4).
Fig. 2 Acute chorioamnionitis. Polyploid aspect of amniotic
membrane with rich inflammatory exudates in the chorioamniotic
axe; edema and exudates in the capsular deciduas - the severity of the
amniochoriodecidual granulocyte reaction suggests just like the acute
marginal choriodecidual inflammation the ascending intrauterine
infection (Hematoxylin-Eosin; ob.10)
Fig. 3 Umbilical vasculitis. Acute intravascular and intraparietal
inflammatory exudates, parietal edema. Umbilical vasculitis, as
funiculitis, is an indicator of maximal specificity (higher positive
predictive value)of microbial invasion of amniotic cavity
(Hematoxylin-Eosin; ob.20)
Fig. 4 Acute inflammation of the chorial board (Acute placentitis)
is the most sensitive indicator (higher negative predictive value) of
microbial invasion of amniotic cavity. Vacuolar decidual dystrophy
with the inflammatory limfoplasmocitary exudates focal suggests the
invasion of the amniotic cavity with Ureaplasma urealyticum (Van
Gieson; ob.20)
Bernal and team [15] show that prevention of preterm labor
complicated with chorioamnionitis is difficult, because
numerous medical and socio-economic predisposing factors
exceed the obstetrician’s control possibilities, suggesting, on
the other hand, that early diagnosis of chorioamnionitis in
pregnant women with preterm labor, by means of rapid and
precise tests, that should be developed (for instance, CRP [19,
20, 21, 22, 23]), followed, as early as possible, by an adequate
treatment with efficient antibiotics and strong and side effects
free anti-inflammatory could stop the preterm labor with a
considerable improvement of the perinatal mortality.
According to Burns group [24], the relation infection-
recurrent abortion is a current active research subject in order
to establish if there is a connection between the inherited
predisposition for the infection and the recurrent abortion
(including the second trimester) or if it is possible to delegate a
strong association between specific groups of vaginal bacteria
and the pregnancy prognosis [5, 7, 11].
The vaginal infections role causing recurrent preterm labor
is a new area of research [25] that seems to orientate with
predilection on the vaginal bacteriosis, defined as the
alteration of the vaginal flora, where the number of the
lactobacillus which usually predominate, is very low or they
are absent [26, 27].
Arias and co-authors [7], in accordance with Spong and
collaborators [11], are mentioning that 70% of preterm labors,
with or without premature rupture of membranes, are the result
of ascending intrauterine infection and placental vasculopathy.
As the Arias group [7], Rai and collaborators [9, 10], and
also Dizon-Townson and co-researchers [28] are suggesting
that the histopathologic examination of the placenta, which
reveals a infarction like placental vasculopathy expanded to
over 10% of the surface, with or without calcifications [29]
and/or accelerated and unequal maturation of the placental villi
next to multiple syncytial nodes, possibly the lack of
adaptation of the decidual spiral arterioles, represents a useful
screening in recurrent late abortions, preterm labor,
preeclampsia and growth delay or fetal death in the uterus.
In addition, the same three groups of researchers, in
accordance with observations of the utero and fetoplacental
arterial flux via ultrasonography [30], agree with the
possibility that the deficiency of the trophoblast to produce
adaptive modifications in the spiral arterioles is the cause of
the inadequate and unequal utero-placental blood flow that
would constitute the basis of both the accelerated maturation,
with numerous syncytial nodes and fibroses of the placental
villi and placental infarctions, of various intensities, knowing,
on the other hand, that thrombophilic defects [10] can generate
either extended placental thromboses or placentation and
embryonic implantation defects.
According to H. Marret and collaborators [31], the
thrombophilias can be acquired (primary and secondary anti
phospholipid syndromes, nephrotic syndromes), congenital
(quantitative and qualitative constitutional deficits in the
natural inhibitors of coagulation: C and S protein and
antithrombin) or mutations that pose an interest to the target
factors of these inhibitors and prevents their action: factor V
Recent Researches in Geography, Geology, Energy, Environment and Biomedicine
ISBN: 978-1-61804-022-0 189
Leiden and that of the prothrombin or G202A10 mutation. To
these one can add some of the more complex anomalies such
as hyperhomocysteinaemia.
The Quinn group [32] observes the fact that the human
infection with Ureaplasma urealyticum is capable to induce the
appearance of antiphospholipid antibodies which are
responsible for thrombotic placental lesions (by reducing the
placental syncytiotrophoblast annexin [24] fig. 5).
Fig. 5 Placental infarction. Fibrinoid necrosis near the atrophic
villi with intense sclero-hyalinization focus, marked calcification –
the last suggesting the possible aggression by antiphospholipid
antibodies type IgM (Hematoxylin-Eosin; ob.10)
The autoimmune explanation for a suggestive proportion of
recurrent abortion, not rarely complicating the second
trimester of pregnancy, is unanimously accepted today, on the
basis of the primary antiphospholipid syndrome which refers
to the association of recurrent abortions to venous thrombosis,
with the demonstration in the laboratory of the
antiphospholipid antibodies persistent in the peripheral blood
[33, 34].
The sanguine screening for antiphospholipid antibodies is
usually repeated in the first weeks of pregnancy for the fact
that some women with recurrent abortions present abnormal
results in this test only during gestation [1].
The resistance to activated C protein is the most studied
thrombophilic defect nowadays, following the primary
antiphospholipid syndrome, in the genesis of recurrent
abortion, which affects with predilection the second gestational
trimester [35].
The resistance to the anticoagulant effects of the activated C
protein is autosomal dominantly inherited and is recognized as
being the most important cause of venous thrombosis (with a
prevalence of up to 60% among people with venous
thrombosis) and familial thrombophilia [9].
In over 90% of resistance to activated C protein cases, the
cause is represented by a ''single point'' mutation (Glutamine-
Arginine) at the nucleotide in position 1691 in the coagulation
factor V gene (Leiden mutation of factor V), and the factor V
with the Leiden mutation is resistant to inactivation through
the activated C protein (which, normally, cleaves and
inactivates the factors Va and VIIIa, in the presence of the
cofactor – the S protein), which leads to the generation of
increased quantities of thrombin and implicitly to a state of
hypercoagulability [3].
Starting from the data provided by the literature of specialty,
drawing the attention both on the placental thrombotic etiology
of late abortion [15, 7, 9], as well as on the large prevalence of
the resistance to activated C protein among those affected by
venous thromboembolic disease, Rai and collaborators [10]
investigated the association of activated C protein resistance to
late abortion.
The results for this investigation of the Ray group [10] show
a prevalence of activated C protein resistance significantly
larger among women with recurrent late abortion in priors,
with respect to those with repeated abortion in the first
trimester, as well as to those from the control group. The
authors conclude that these results suggest that the resistance
to activated C protein can be an important mechanism of late
abortion, possibly connected to the intravascular
hypercoagulability which accompanies the pregnancy,
knowing that the activated C protein resistance is developed
during pregnancy as a part of the normal hemostatic
modifications of the pregnancy, which makes women with
activated C protein resistance, preceding the pregnancy,
develop an even more accentuated activated C protein
resistance once the pregnancy installs and evolves with time.
Rotmensch and collaborators [35] indicate the necessity of
introducing, in the standardized investigation of the recurrent
abortion, of the repeated screening for the activated C protein
resistance, alongside the molecular diagnosis for the Leiden
mutation of the coagulation factor V.
Fig. 6 Umbilical vein thrombosis. Endothelial lesions. Parietal
edema (Van Gieson; magnifier)
The Rai group [9, 10] completes the list of thrombophilic
defects exploration with the dosing of antithrombin III, of C
protein and of S protein (total and free) concentration, of
factor XII, of fibrinogen, plasminogen and of the normality of
the fibrin plate lysis, but also of acquired or congenital
hyperhomocysteinaemia (rapidly correctable by means of folic
acid supplements), which, although much rarer than the
antiphospholipid antibodies and resistance to activated C
protein are nowadays more and more frequently associated to
the second trimester abortion via extended placental infarction.
Dizon - Townson and the co-researchers [28] mention,
nonetheless, that 42% of the placentas with over 10% of the
surface infarcted reflect the fetus’s state of carrier of the factor
V Leiden mutation (the most frequent genetic predisposition to
Recent Researches in Geography, Geology, Energy, Environment and Biomedicine
ISBN: 978-1-61804-022-0 190
thrombosis, often marked by the umbilical blood vessels
thrombosis, alongside extended placental infarction – fig. 6).
III. CONCLUSIONS
The fact that the etiopathogeny of late abortion and preterm
birth is dominated by the placental vasculopathy and by the
ascending intrauterine infection, in the conditions of the
possibility of excluding the vasculopathy as early as the
asymptomatic phase of the intrauterine infection, by means of
the serum CRP screening, focuses the attention to the necessity
of routinely applying, in case of late abortion and preterm
birth, of the histopathologic exam of the conception product,
as an essential step of orientation of the standard complex
investigation of recurrent abortion, which would allow not
only important economies of funds, time and emotions for the
maternity and the affected families, but also the application of
modern, preventive and curative therapy in the early stages of
preterm labor, when, evidently, the systematic classical
tocolysis appears superfluous.
Because of the large percentage of extended placental
thromboses which are caused by the Leiden mutation of factor
V, the most frequent genetic predisposition to venous
thromboses, it is necessary to adopt as early as possible, in the
investigation of the etiology of late spontaneous abortion, the
exploration of the activated C protein resistance, which once
detected in case of a patient with abortion, especially a
recurrent one, imposes the exploration of her relatives, thus
increasing efficiency, not only in fighting recurrent abortion by
starting the antithrombotic therapy before conception, but also
the risk of thrombosis in the general population.
REFERENCES
[1] St Mary's NHS Trust, Recurrent miscarriage clinic, 1998.
[2] I. Munteanu, Avortul, Tratat de obstetrica, editia II, vol 2, Bucuresti,
Editura Academiei Romane, 815-848, 2006.
[3] R. Rai, L. Reagan, E. Hadley, M. Dave, H. Cohen, “Second trimester
pregnancy loss is associated with activated C resistance”, Br Haematol,
92:489, 1996
[4] G. Wolf, E. Horger, “Indications for examination of spontaneous
abortion specimens: A reassessment”, Am J Obstet Gynecol, 173:1364,
1995
[5] R. Romero, C.M. Salafia, A.P. Athanassiadis, S. Hanaoka, M. Mazor,
W. Sepulveda, M.B. Braken, “The relationship between acute
inflammatory lesions of the preterm placenta and amniotic fluid
microbiology”, Am J Obstet Gynecol, 166:1382, 1992.
[6] R. Romero, R. Gonzales, W. Sepulveda, F. Brandt, M. Ramirez, Y.
Sorokin, M. Mazor, M.C. Treadwell, D.B. Cotton, “Infection and labor.
VIII. Microbial invasion of the amniotic cavity in patients with
suspected cervical incompetence: prevalence and clinical significance”,
Am J Obstet Gynecol, 167: 1086, 1992.
[7] F. Arias, L. Rodrigues, L. Rayne, F.T. Krau, “Maternal placental
vasculopaty and infection: Two distinct subgroups among patients with
preterm labor and preterm ruptured membranes”, Am J Obstet Gynecol,
168: 585, 1993.
[8] R. Rai, K. Clifford, L. Regan, “The modern preventive treatment of
recurrent miscarriage”, Br J Obstet Gynaecol, 103: 106, 1996
[9] R. Rai, L. Regan, A. Chitolie, J.G. Donald, H. Cohen, “Placental
thrombosis and second trimester miscarriage in association with protein
C resistance”, Br J Obstet Gynaecol, 103: 842, 1996
[10] R. Rai, L. Regan, H. Cohen, “Thrombophilic defects and pregnancy
loss”, Infertility and Reproductive medicine clinics of North
America,7(4):745, 1996
[11] C.Y. Spong, A. Ghidini, D. Sherer, J.C. Pezzullo, M. Ossandon, G.S.
Eglinton, “Angiogenin: A marker for preterm delivery in midtrimester
amniotic fluid”, Am J Obstet Gynecol, 176: 415, 1997.
[12] M.J.N.C. Keirse, “New perspectives for effective treatment of preterm
labor”, Am J Obstet Gynecol, 173: 618, 1995.
[13] M. Delcroix, C. Gomez, “Urgences obtetricales”, Soins en Gynecologie
Obstetrique, Paris, Ed.Maloine, 270-273, 2005
[14] M.F. Păun, C. Bulucea, M. Niculescu, M. Dumitru, “Retrospectivă
clinico-morfologică asupra avortului recurent in trimestrul doi”,
Obstetrica şi Ginecologia, Revista Societăţii Române de Obstetrică şi
Ginecologie 3: 219-223, 2000
[15] A.L. Bernal, D.J. Hansell, T.Y. Khong, J.W. Keeling, A.C. Turnbull,
“Prostaglandin E production by the fetal membranes in unexplained
preterm labor and preterm labor associated with chorioamnionitis”, Br J
Obstet Gynecol, 96: 1133, 1989.
[16] C. Bulucea, M.F. Paun, Actualitati in avortul tardiv, Ed. Fundatia
Scrisul Romanesc, Craiova, 1999
[17] C.A. Bulucea, N.E. Mastorakis, M.F. Paun, R.N. Marcu,
“Histopathological placental screening as valuable and non-invasive
method for assessing etiology of second trimester recurrent abortion”,
Advances in biomedical research, Proceedings, published 2010, 180-
186, Proceedings of the International Conferences on Medical
Pharmacology/Medical Histology and Embryology/Psychiatry and
Psychotherapy/International Conference on Oncology, University of
Cambridge, Cambridge, England, February 23-25, 2010
[18] C.A. Bulucea, N.E. Mastorakis, M.F. Paun, A.D. Neatu, A.G. Neatu,
“Pleading for the routine introduction in the investigation of the late
spontaneous abortion etiology of the exploration of resistance to
activated C protein along with histopathological placentary screening”,
WSEAS Transactions on Biology and Biomedicine, Issue 3, Volume 7,
146-157, July 2010
[19] C. Bulucea, M. Păun, “Proteina C-reactivă (CRP) serică în trimestrul
doi de sarcină normală şi patologică cât şi postabortum tardiv
necomplicat”, Obstetrica şi Ginecologia, Revista Societăţii Române de
Obsterică şi Ginecologie 4: 237-242, 1998.
[20] M.F. Paun, C. Bulucea, “C-reative protein in midtrimester pregnancy
and in the post-abortum period”, Reproduction – European Society of
Human Reproduction and Embryology: Oxford University Press,
Volume 14, Abstract, Book I: 362-363, June 1999
[21] C. Bulucea, N. Mastorakis, M. Paun, A. Neatu, “Evaluating the
infection in the second trimester of pregnancy by C-reactive protein
dosing”, North Atlantic University Union Proceedings of the World
Medical Conference, 149-155, Malta, 2010
[22] C. Bulucea, N. Mastorakis, M. Paun, A. Neatu, “The infectious etiology
of second trimester spontaneous abortion reflected in the peripheral
blood”, International Journal of Biology and Biomedical Engineering,
NAUN Publication, Issue 1, Vol. 4, 2010, 10-21
[23] C. Bulucea, N. Mastorakis, M. Paun, A. Neatu, “Quantitative
measurement of the serum C reactive protein in different clinic
categories of late spontaneous and therapeutic abortion”, Recent
Researches in Modern Medicine, 2011, 351-358, Proceedings of the 2nd
International Conference on MEDICAL PHYSIOLOGY
(PHYSIOLOGY '11), the 2nd International Conference on MEDICAL
PHARMACOLOGY (PHARMACOLOGY '11), , the 2nd International
Conference on BIOCHEMISTRY and MEDICAL CHEMISTRY
(BIOMEDCH '11), the 2nd International Conference on MEDICAL
HISTOLOGY and EMBRYOLOGY (HISTEM '11), 2nd International
Conference on ONCOLOGY (ONCOLOGY '11) and the 2nd
International Conference on PSYCHIATRY and PSYCHOTHERAPY
(PSYCHO '11), University of Cambridge, Cambridge ENGLAND,
February 20-25, 2011
[24] D.N. Burns, P. Nourjah, H. Minkoff, J. Korelitz, R.J. Biggar, S.
Landesman, A. Rubinstein, D. Wright, R.P. Nugent, “Changes in CD4+
and CD8+ cell levels during pregnancy and postpartum in women
seropositive and seronegative for human immunodeficiency virus-1”,
Am J Obstet Gynecol, 174: 1461, 1996
[25] E.R. Newton, J. Piper, W. Peairs, “Bacterial vaginosis and intraamniotic
infection”, Am J Obstet Gynecol, 176: 672, 1997.
[26] M.N.J.C. Keirse, H. McDonald, “Infection and preterm labor”, Progress
in preterm, 1(2): 5, 1996.
[27] M. Delcroix, C. Gomez, “Infections gynecologiques”, Soins en
Gynecologie Obstetriques, Paris, Ed. Maloine, 79-93, 2005
Recent Researches in Geography, Geology, Energy, Environment and Biomedicine
ISBN: 978-1-61804-022-0 191
[28] D.S. Dizon-Townson, L. Meline, L.M. Nelson, M. Varner, K. Ward,
“Fetal carriers of the factor V Leiden mutation are prone to miscarriage
and placental infarction”, Am J Obstet Gynecol,177: 402, 1997.
[29] J.H. Rand, X.X. Wu, S. Guller, J. Scher, H.A.M. Andree, C.J.
Lockwood, “Antiphospholipid immunoglobulin G antibodies reduce
annexin - V levels on syncytiotrophoblast apical membranes and in
culture media of placental villi”, Am J Obstet Gynecol, 177: 918, 1997
[30] A.V. Logvinenko, N.M. Mamedalieva, B.E. Rozenfeld, “The
characteristics of the fetal-maternal-placental blood flow in habitual
abortion”, Akush Ginekol Mosk, 4: 22, 1993
[31] H. Marret, J. Wagner-Ballon, H. Guyot, “Grossesse et trombophilie”,
101 questions en gynecologie - obstetrique, Paris, Ed. Masson, 88-92,
2004
[32] P.A. Quinn, M. Petric, M. Barkin, J. Butany, C. Derzko, M. Gysler, K.I.
Lie, A.B. Shewchuck, J. Shuber, E. Ryan, M.L. Chipman, “Prevalence
of antibody to Chlamydia trachomatis in spontaneous abortion and
infertility”, Am J Obstet Gynecol, 156: 291, 1987.
[33] R.M. Silver, S.S. Pierangeli, SS. Edwin, F. Umar, N.E. Harris, J.R.
Scott, W.D. Branch, “Pathogenic antibodies in women with obstetric
features of antiphospholipid syndrome who have negative test results for
lupus anticoagulant and anticardiolipin antibodies”, Am J Obstet
Gynecol, 176: 628, 1997
[34] C. Bulucea, N. Mastorakis, M. Paun, A. Neatu, “Immunological
Characterization of Late Miscarriage”, WSEAS TRANSACTIONS on
Biology and Biomedicine, Issue 3, Volume 7, 136-145, July 2010
[35] S. Rotmensch, M. Liberati, M. Mittlemann, Z. Ben-Rafael, “Activated
protein C resistance and adverse pregnancy outcome”, Am J Obstet
Gynecol, 177:170, 1997
Recent Researches in Geography, Geology, Energy, Environment and Biomedicine
ISBN: 978-1-61804-022-0 192